 Interpace Diagnostics Group NASDAQ:IDXG was downgraded by stock analysts at ValuEngine from a strong-buy rating to a buy rating in a research note issued on Friday, ValuEngine reports. A number of other equities analysts have also commented on the stock. Maxim Group reaffirmed a buy rating and issued a 12.00 price objective on shares of ... 